Morpheridine

Morpheridine
Clinical data
ATC code	none;
Legal status
Legal status	AU: S9 (Prohibited substance); BR: Class A1 (Narcotic drugs); CA: Schedule I; DE: Anlage I (Authorized scientific use only); UK: Controlled Drug; US: Schedule I; UN: Psychotropic Schedule I;
Identifiers
	IUPAC name ethyl 1-(2-morpholin-4-ylethyl)-4-phenyl-piperidine-4-carboxylate;
CAS Number	469-81-8 ;
PubChem CID	61121;
ChemSpider	55069 ;
UNII	1854GKB41Y;
CompTox Dashboard (EPA)	DTXSID20196979 ;
ECHA InfoCard	100.006.749
Chemical and physical data
Formula	C20H30N2O3
Molar mass	346.471 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(OCC)C3(c1ccccc1)CCN(CCN2CCOCC2)CC3;
	InChI InChI=1S/C20H30N2O3/c1-2-25-19(23)20(18-6-4-3-5-7-18)8-10-21(11-9-20)12-13-22-14-16-24-17-15-22/h3-7H,2,8-17H2,1H3 ; Key:JDEDMCKQPKGSAX-UHFFFAOYSA-N ;
	(verify)

Morpheridine (Morpholinoethylnorpethidine) is a 4-phenyl piperidine derivative that is related to the clinically used opioid analgesic drug pethidine (meperidine). It is a strong analgesic with around 4 times the potency of pethidine, and unlike pethidine, does not cause convulsions, although it produces the standard opioid side effects such as sedation and respiratory depression.

Morpheridine is not currently used in medicine and is a Schedule I drug which is controlled under UN drug conventions.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.